<DOC>
	<DOCNO>NCT02494895</DOCNO>
	<brief_summary>To compare clinical outcome dual antiplatelet therapy aspirin ticagrelor vs. ticagrelor monotherapy 3 month PCI patient acute coronary syndrome .</brief_summary>
	<brief_title>Ticagrelor Monotherapy After 3 Months Patients Treated With New Generation Sirolimus Stent Acute Coronary Syndrome ( TICO Study )</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patients ≥ 19 year old Patients receive new generation sirolimuseluting ( Osiro® ) stent implantation treat ACS Patients without significant clinical event MI , stent thrombosis revascularization 3 month PCI Provision inform consent Age &gt; 80 year Increased risk bleeding , anemia , thrombocytopenia A need oral anticoagulation therapy Pregnant woman woman potential childbearing Life expectancy &lt; 1 year Patients treat strong CYP3A4 inhibitor ( e.g . ketoconazole , clarithromycin , nefazodone , ritonavir , atazanavir ) Patients history intracranial hemorrhage Moderate severe hepatic dysfunction Increased risk bradycardiarelated symptom ( Guidance reference )</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>